Chris Kiesnowski
About Chris Kiesnowski
Chris Kiesnowski is the Associate Director of the External Analytical Strategy & Management Group at Bristol-Myers Squibb, with over 30 years of experience in the pharmaceutical industry.
Company
Chris Kiesnowski is currently working at Bristol-Myers Squibb, a leading global biopharmaceutical company. He has been with the organization for over three decades, which showcases his commitment and expertise within the company. Given his extensive experience, he has held various roles, specifically within the External Analytical Strategy & Management Group (EASM).
Title
Chris Kiesnowski is the Associate Director at the External Analytical Strategy & Management Group (EASM), a position that emphasizes his leadership within the company. His responsibilities in this role involve strategic engagement with external partners and overseeing analytical projects.
Education and Expertise
Chris Kiesnowski studied Analytical Chemistry at Rutgers University Cook College, earning a Bachelor of Applied Science (BASc) from 1980 to 1984. His education laid a strong foundation for his career in the pharmaceutical industry, where he has accumulated over 30 years of experience. His expertise is specifically in analytical strategy and management.
Background
Chris Kiesnowski began his career in the pharmaceutical industry at Bristol-Myers Squibb, starting as Group Leader in the External Analytical Strategy & Management Group (EASM) in 1988. Over the course of 31 years in this position, he has developed extensive knowledge and skills, which facilitated his transition to Associate Director. His long-term tenure and career progression within the company underline his significant contributions and experience in the field.
Experience in Analytical Strategy and Management
Chris Kiesnowski's career spans over three decades, during which he has specialized in external analytical strategy and management. This involves close collaboration with external partners and diligent oversight of analytical projects. His role signifies his extensive knowledge and capability in managing and leading strategic analytical initiatives within a major biopharmaceutical company.